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Pseudomonas oeruginoso is responsible for 65% of mortality in hospitals all over the world. Its prevalence is 
attributed to factors such as: intrinsic resistance determined by virulence factors; acquired resistance 
mechanisms that lead to a low susceptibility to antimicrobial agents; and ability to attach to any natural and 
artificial surfaces and form biofilms. The emergence of new strategies to control P. aeruginosa biofilms is 
becoming more evident due to their tolerance to traditional treatments and bacteriophages have been 
recognized as an attractive alternative for this problem. Nevertheless, despite the potential of phages as 
antimicrobial agents, it is well known that bacteria can quickly adapt and create new survival strategies and the 
emergence of phage-resistant phenotypes is inevitable. Thus, the combination of phage and antibiotic therapies 
could have potentially more benefits than just using phages and antibiotics alone. This work describes the 
combinatory treatment using P. aerug1nosa phages and antibiotics (amikacin, ciprofloxacin, piperacillin and 
tetracycline) against biofilms. The efficacy of phages and antibiotics were evaluated by the enumeration of viable 
cells and the determination of biofilm biomass. All antibiotics tested showed little efficacy against biofilms 
which were also very tolerant to phage infection, partially due to the fast emergence of resistant phenotypes 
with LPS mutations. However, the association of phage and ciprofloxacin caused a 100% biofilm removal. 
Synergy was observed with a combined phage-dprofloxacm treatment, and overall an additive effect was seen 
with piperacillin and tetracyclin. Antagonism was observed with amikacin. Nevertheless, all antibiotic-phage 
combined treatments caused the disruption of the biofilm matrix. The effectiveness of combined treatments 
with phages and antibiotics can be due to several factors, namely high burst sizes in cells exposed to antibiotics 
(ex. piperacillin), lower MIC values and altered surface charges of phage resistant phenotypes and disruption of 
the biofilm matrix induced by some of the phages which can enhance the antibiotic penetration. 
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